Association of severity of COPD with IgE and interleukin-1beta

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 73, Issue 2, 2010, Pages 86-87

  Singh, Bhawna ^a   Arora, S ^b   Khanna, V ^c  

^a G B PANT HOSPITAL   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

^c Government of National Capital Territory   (India)

Author keywords

Airways; Cytokines; IgE; IL 1 beta; Pro inflammatory; Smoking

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MALE;

EID: 77956993930     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2010.303     Document Type: Article

References (11)

1. Vollmer WM, Buist AS, Johnson LR, McCamant LE, Halonen M. Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies. Chest 1986; 90: 416-423.
2. Asada M, Yamaya M, Ebihara S, et al. Interleukin-1β Gene Polymorphisms Associated With COPD. Chest 2005; 128: 1072-1073.
3. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304-1309.
4. Kips JC, Pauwels RA. Are cytokines responsible for the asthmatic state of the airway? Monaldi Archives for Chest Disease 1996; 51: 223-227.
5. Bernstein IL. Isocyanate-induced pulmonary diseases: a current perspective. J Allerg Clin Immunol 1982; 70: 24-31.
6. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
7. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
8. Renkema TEJ, Kerstjens HAM, Schouten JP, Vonk JM, Koëter GH, Postma DS. The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD. Clin Exp Allergy 1998; 28: 1210-1218.
9. Sapey E, Ahmad A, Bayley D, et al. Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD. J Clin Immunol 2009; 29: 508-516.
10. Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A. Smoking cessation, decline in pulmonary function and total mortality: a 30-year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 2001; 56: 703-707.
11. Mahajan B, Vijayan VK, Agarwal MK, Bansal SK. Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease. Biomarkers 2008; 13: 713-727.